[Press release] Bioplus has secured the management rights of “Ubiprotein” to develop next-generation protein drugs 2021년 October 22일 By bioplubiz
[Press release] BioPlus secured the site of the Seongbon Industrial Complex in Chungbuk for 16.5 billion won, and “expanded production facilities” 2021년 October 19일 By bioplubiz
[Press release] Ubiprotein and Bioplus are promoting joint development of next-generation improved obesity treatments 2021년 September 28일 By bioplubiz
[Press release] BioPlus, which has 6.6 trillion won in subscriptions, “Leaps as a bio company that encompasses treatment and beauty.” 2021년 September 23일 By bioplubiz
[Press release] Bioplus, application of biomaterials and creation of new growth engines for bio-industry 2021년 September 9일 By bioplubiz
[Press release] BioPlus is focusing on the world’s only hyaluronic acid platform technology. 2021년 July 30일 By bioplubiz
[Press release] BioPlus passed preliminary screening on KOSDAQ listing, Promotion of IPO and overseas expansion 2021년 July 30일 By bioplubiz
